X

Trial Profile

Pot-Cast: Thrombosis Prophylaxis During Plaster Cast Lower Leg Immobilisation: Determining the Balance Between Benefits and Risks.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 16 Dec 2016

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dalteparin sodium (Primary) ; Nadroparin calcium (Primary) ; Low molecular weight heparins
Indications Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism
Focus Adverse reactions; Therapeutic Use
Acronyms Pot-Kast

Most Recent Events

03 Dec 2016 Results of two trials (POT-KAST and POT-CAST) published in the New England Journal of Medicine
10 Oct 2016 Status changed from active, no longer recruiting to completed.
31 May 2016 Planned End Date changed from 1 Dec 2016 to 1 Jun 2016.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com